Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Radient Pharmaceuticals Corp.

www.radient-pharma.com

Latest From Medtronic Sofamor Danek USA Inc.

NuVasive Eyes Further Expansion In Spinal Market

NuVasive is determined to put the turmoil of recent months behind it. With a new management team in place, the company aims to become the market leader in spine through innovation and increased adoption of minimally invasive approaches.

Medical Device Business Strategies

Deals Shaping The Medical Industry, June 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type –Acquisition, Alliance, or Financing.

BioPharmaceutical Medical Device

Deals Shaping the Medical Industry (07/2011)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions.

OrthoSensor: Will Sensor-Enabled Data Transform Orthopedics?

OrthoSensor is trying to bring a data-driven revolution to orthopedics. It is building a three-legged platform, with intelligent instruments, intelligent implants, and analytics, all driven by sensor and other micro-electronics technology that feed back to surgeons vital data both intra- and post-operatively. Critical to its strategy: that improving outcomes in orthopedic surgery rests on developing better, data-rich surgical techniques, rather than novel implants made of new materials or design features.
Medical Device
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • AMDL Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Radient Pharmaceuticals Corp.
  • Senior Management
  • Douglas MacLellan, Chmn. & CEO
    Akio Ariura, CFO & COO
  • Contact Info
  • Radient Pharmaceuticals Corp.
    Phone: (714) 505-4460
    2492 Walnut Ave.
    Ste. 100
    Tustin, CA 92780
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register